Ortin Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 14.57 million compared to INR 22.94 million a year ago. Revenue was INR 14.86 million compared to INR 24.52 million a year ago. Net loss was INR 1.77 million compared to INR 4.53 million a year ago. Basic loss per share from continuing operations was INR 0.22 compared to INR 0.56 a year ago.
For the full year, sales was INR 60.2 million compared to INR 82.31 million a year ago. Revenue was INR 60.62 million compared to INR 84.25 million a year ago. Net loss was INR 0.669 million compared to INR 3.99 million a year ago. Basic loss per share from continuing operations was INR 0.08 compared to INR 0.49 a year ago.